Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Leukemia Therapeutic market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Leukemia Therapeuticmarket, defines the market attractiveness level of Leukemia Therapeutic market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Leukemia Therapeutic industry, describes the types of Leukemia Therapeutic market, the applications of major players and the market size, and deeply analyzes the current situation of the global Leukemia Therapeutic market and the development prospects and opportunities of Leukemia Therapeutic industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Leukemia Therapeutic market in Chapter 13.
By Player:
Novartis International
Celgene Corporation
Roche Holding
Pfizer
Ariad Pharmaceuticals
Clavis Pharma
Genzyme
Sunesis Pharmaceuticals
By Type:
Induction Therapy
Consolidation Therapy
Maintenance Therapy
By End-User:
Cancer Research Centers
Diagnostic Laboratories
Clinics
Hospitals
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Leukemia Therapeutic Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Leukemia Therapeutic Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Leukemia Therapeutic Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Leukemia Therapeutic Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Leukemia Therapeutic Market Analysis and Outlook to 2022
-
7.1 Global Leukemia Therapeutic Consumption (2017-2022)
-
7.2 United States Leukemia Therapeutic Consumption (2017-2022)
-
7.3 Europe Leukemia Therapeutic Consumption (2017-2022)
-
7.4 China Leukemia Therapeutic Consumption (2017-2022)
-
7.5 Japan Leukemia Therapeutic Consumption (2017-2022)
-
7.6 India Leukemia Therapeutic Consumption (2017-2022)
-
7.7 South Korea Leukemia Therapeutic Consumption (2017-2022)
8 Region and Country-wise Leukemia Therapeutic Market Analysis and Outlook to 2028
-
8.1 Global Leukemia Therapeutic Consumption Forecast (2022-2028)
-
8.2 United States Leukemia Therapeutic Consumption Forecast (2022-2028)
-
8.3 Europe Leukemia Therapeutic Consumption Forecast (2022-2028)
-
8.4 China Leukemia Therapeutic Consumption Forecast (2022-2028)
-
8.5 Japan Leukemia Therapeutic Consumption Forecast (2022-2028)
-
8.6 India Leukemia Therapeutic Consumption Forecast (2022-2028)
-
8.7 South Korea Leukemia Therapeutic Consumption Forecast (2022-2028)
9 Global Leukemia Therapeutic Market Outlook by Types and Applications to 2022
-
9.1 Global Leukemia Therapeutic Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Induction Therapy Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Consolidation Therapy Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Maintenance Therapy Consumption and Growth Rate (2017-2022)
-
9.2 Global Leukemia Therapeutic Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Cancer Research Centers Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Diagnostic Laboratories Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Clinics Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Hospitals Consumption and Growth Rate (2017-2022)
10 Global Leukemia Therapeutic Market Outlook by Types and Applications to 2028
-
10.1 Global Leukemia Therapeutic Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Induction Therapy Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Consolidation Therapy Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Maintenance Therapy Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Leukemia Therapeutic Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Cancer Research Centers Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Diagnostic Laboratories Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
11 Global Leukemia Therapeutic Import and Export Analysis (Top 5 Countries)
-
11.1 Global Leukemia Therapeutic Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Leukemia Therapeutic Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Leukemia Therapeutic Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Leukemia Therapeutic Market Competitive Analysis
-
14.1 Novartis International
-
14.1.1 Novartis International Company Details
-
14.1.2 Novartis International Leukemia Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Novartis International Leukemia Therapeutic Product and Service
-
14.2 Celgene Corporation
-
14.2.1 Celgene Corporation Company Details
-
14.2.2 Celgene Corporation Leukemia Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Celgene Corporation Leukemia Therapeutic Product and Service
-
14.3 Roche Holding
-
14.3.1 Roche Holding Company Details
-
14.3.2 Roche Holding Leukemia Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Roche Holding Leukemia Therapeutic Product and Service
-
14.4 Pfizer
-
14.4.1 Pfizer Company Details
-
14.4.2 Pfizer Leukemia Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Pfizer Leukemia Therapeutic Product and Service
-
14.5 Ariad Pharmaceuticals
-
14.5.1 Ariad Pharmaceuticals Company Details
-
14.5.2 Ariad Pharmaceuticals Leukemia Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Ariad Pharmaceuticals Leukemia Therapeutic Product and Service
-
14.6 Clavis Pharma
-
14.6.1 Clavis Pharma Company Details
-
14.6.2 Clavis Pharma Leukemia Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Clavis Pharma Leukemia Therapeutic Product and Service
-
14.7 Genzyme
-
14.7.1 Genzyme Company Details
-
14.7.2 Genzyme Leukemia Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Genzyme Leukemia Therapeutic Product and Service
-
14.8 Sunesis Pharmaceuticals
-
14.8.1 Sunesis Pharmaceuticals Company Details
-
14.8.2 Sunesis Pharmaceuticals Leukemia Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Sunesis Pharmaceuticals Leukemia Therapeutic Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Leukemia Therapeutic
-
Figure Leukemia Therapeutic Picture
-
Table Global Leukemia Therapeutic Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Leukemia Therapeutic Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Leukemia Therapeutic Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Leukemia Therapeutic Consumption by Country (2017-2022)
-
Figure United States Leukemia Therapeutic Consumption and Growth Rate (2017-2022)
-
Table Europe Leukemia Therapeutic Consumption and Growth Rate (2017-2022)
-
Figure China Leukemia Therapeutic Consumption and Growth Rate (2017-2022)
-
Figure Japan Leukemia Therapeutic Consumption and Growth Rate (2017-2022)
-
Figure India Leukemia Therapeutic Consumption and Growth Rate (2017-2022)
-
Figure South Korea Leukemia Therapeutic Consumption and Growth Rate (2017-2022)
-
Figure Global Leukemia Therapeutic Consumption Forecast by Country (2022-2028)
-
Figure United States Leukemia Therapeutic Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Leukemia Therapeutic Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Leukemia Therapeutic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Leukemia Therapeutic Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Leukemia Therapeutic Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Leukemia Therapeutic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Induction Therapy Consumption and Growth Rate (2017-2022)
-
Figure Global Consolidation Therapy Consumption and Growth Rate (2017-2022)
-
Figure Global Maintenance Therapy Consumption and Growth Rate (2017-2022)
-
Figure Global Cancer Research Centers Consumption and Growth Rate (2017-2022)
-
Figure Global Diagnostic Laboratories Consumption and Growth Rate (2017-2022)
-
Figure Global Clinics Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Induction Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Consolidation Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Maintenance Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cancer Research Centers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Diagnostic Laboratories Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Leukemia Therapeutic Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Leukemia Therapeutic Export by Region (Top 5 Countries) (2017-2028)
-
Table Novartis International (Foundation Year, Company Profile and etc.)
-
Table Novartis International Leukemia Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis International Leukemia Therapeutic Product and Service
-
Table Celgene Corporation (Foundation Year, Company Profile and etc.)
-
Table Celgene Corporation Leukemia Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Celgene Corporation Leukemia Therapeutic Product and Service
-
Table Roche Holding (Foundation Year, Company Profile and etc.)
-
Table Roche Holding Leukemia Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Holding Leukemia Therapeutic Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Leukemia Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Leukemia Therapeutic Product and Service
-
Table Ariad Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Ariad Pharmaceuticals Leukemia Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Ariad Pharmaceuticals Leukemia Therapeutic Product and Service
-
Table Clavis Pharma (Foundation Year, Company Profile and etc.)
-
Table Clavis Pharma Leukemia Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Clavis Pharma Leukemia Therapeutic Product and Service
-
Table Genzyme (Foundation Year, Company Profile and etc.)
-
Table Genzyme Leukemia Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Genzyme Leukemia Therapeutic Product and Service
-
Table Sunesis Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Sunesis Pharmaceuticals Leukemia Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sunesis Pharmaceuticals Leukemia Therapeutic Product and Service
-
